Back to the analysis
Source figures
Every number in this analysis comes from AIOS's posting for Head of Product Growth
(Referrals & Viral Loops), read on 9 September 2026.
Original: jobs.ashbyhq.com/Aios/e0971cdd-b061-4530-ae6e-d45d58714529
Primary KPI: 30-day K factor
| Measure | Value |
|---|
| End of 26Q1 | 0.0835 |
| Base | 0.17 |
| Target | 0.30 |
| Stretch | 0.42 |
Defined in the posting as additional net new customers brought in by each net new
customer within 30 days of their initial purchase.
Secondary KPI: UK monthly net referral rate
| Measure | Value |
|---|
| End of 26Q1 | 7.83% |
| Base | 16% |
| Target | 25% |
| Stretch | 30% |
Net referrals in the last 30 days over net active customers.
Tertiary KPIs, end of 26Q1
| Measure | Value |
|---|
| Advocate share, customers who have referred at least once | 10.22% |
| Referral frequency per successful advocate | 1.27 |
| Average days to first referral | 26.8 |
| New customers sharing the link within 1000 seconds of purchase (April 2026) | 1.21% |
Company figures quoted in the same posting
| Measure | Value |
|---|
| ARR | $350M |
| ARR 12 months earlier | $10M |
| Patients served monthly via Bolt Pharmacy | >150k |
| UK active GLP-1 patients, 12 months earlier to now | 3k to 150k |
| Stated goal for active customers by 2030 | 10 million |
Held here because job postings come down. The figures above are AIOS's own,
reproduced for verification, with the original linked at the top.